We are live on
!
Find out more
Bioventus
BVS
BVS
157 hedge funds and large institutions have $466M invested in Bioventus in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 56 increasing their positions, 47 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
447% more call options, than puts
Call options by funds: $1.95M | Put options by funds: $357K
76% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 17
25% more capital invested
Capital invested by funds: $373M → $466M (+$92.9M)
19% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 47
6% more funds holding
Funds holding: 148 → 157 (+9)
0.83% more ownership
Funds ownership: 74.96% → 75.79% (+0.83%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
157
Holders Change
+9
Holders Change %
+6.08%
% of All Funds
1.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
56
Reduced
47
Closed
17
Calls
$1.95M
Puts
$357K
Net Calls
+$1.6M
Net Calls Change
+$715K
Top Buyers
Top Sellers
| 1 |
BCA
Buckley Capital Advisors
Miami Beach,
Florida
|
-$2.71M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.65M |
| 3 |
EP
Eversept Partners
New York
|
-$2.62M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$1.91M |
| 5 |
Jane Street
New York
|
-$1.72M |
